MedPath

Lymph Node Ratio as a Predictor for Outcome in Rectal Cancer

Conditions
Recurrence
Registration Number
NCT05221684
Lead Sponsor
Mansoura University
Brief Summary

This study aims to evaluate the value of the LNR as a prognostic indicator in patients with rectal cancer who offered total mesorectal excision.

Detailed Description

Patients and methods Study design and setting This is a retrospective review of prospectively collected and maintained database of patients with CRC admitted in the Oncology Center of Mansoura University (OCMU), the Colorectal Surgery Unit of Mansoura University Hospitals, and the Department of General Surgery of Alexandria University.

Selection criteria Patients of either gender aged 18 years or above who presented with rectal cancer of any stage will be included in the study. We will exclude patients with patients younger than 18 years; patients with synchronous colon cancer; synchronous liver, pulmonary or bones metastasis; or synchronous gastrointestinal cancer; or patients who were lost to follow-up.

Study endpoints The primary endpoint of the study is to assess the value of lymph node ratio (LNR) on the oncological outcomes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • rectal cancer of TNM stage I-III
  • underwent radical resection with curative intent
Read More
Exclusion Criteria
  • synchronous colon cancer
  • synchronous gastrointestinal cancer
  • underwent palliative resection
  • presented with intestinal obstruction
  • those lost to follow-up.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Lymph node valueone year

Value in prediction of oncological outcomes

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mansoura Faculty of Medicine

🇪🇬

Mansoura, Dakahliya, Egypt

© Copyright 2025. All Rights Reserved by MedPath